Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MDA - Market Direction Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (55474)	6/27/2000 3:22:00 PM
From: pater tenebrarum	Read Replies (1) \| Respond to of 99985

TA, i hope you realize that according to the BLS this 17,4% price rise never took place...these folks at Express Scripts are hallucinating...:) regards, hb

To: Tunica Albuginea who wrote (55474)	6/27/2000 5:59:00 PM
From: el paradisio	Read Replies (1) \| Respond to of 99985

OTTA,still 1+1 is not equal 2. Here,we have 17.4% <Spending on prescription drugs in the U.S. rose a record 17.4% last year, with seniors over age 70 hardest hit by rising drug prices, according to a new analysis by a big pharmacy-benefit manager.> Here,we have 13.7% <For instance, the price of two popular hormone-replacement drugs -- Premarin and Prempro, both made by American Home Products Corp. -- rose 12.1% in 1999, according to the study. The price of Glucophage for diabetes, from Bristol-Myers Squibb Co., increased 14.5%, while Serevent, an antiasthmatic from Glaxo Wellcome PLC, rose 14.6%.> 17.4% + 13.7%=31.1% And the stock price of AHP is still the same in last 12 month and BMY is minus 30%. el